Tuesday 15 September 2009
A promising new drug may be able to treat more types of cancer than first thought. PARP inhibitors have shown early promise for treating cancers linked to BRCA gene mutations, including some breast and ovarian cancers.
>> http://news.bbc.co.uk/2/hi/health/8256494.stm
Recent stories
Most people told to get a colonoscopy don't
>> Find out more
MASCC/ISOO early rate deadline approaching
>> Find out more
Ten biomarkers for lung cancer detection
>> Find out more
Book for high-level conference on health funding
>> Find out more
New strategy to help charities deal with fraud
>> Find out more
Seminar on financial sustainability for charities
>> Find out more
Diesel exhaust linked to lung cancer deaths
>> Find out more
Identify depressive symptoms early in breast cancer patients
>> Find out more
Antibiotics may help gastric DLBCL patients avoid chemo
>> Find out more
Early registration deadline for GI conference extended to Fri
>> Find out more
Medical paternalism: who knows best?
>> Find out more
Risk of fatal adverse events in VEGF-targeting cancer drugs
>> Find out more
EBMT 2012: registration open
>> Find out more
Latest issue of Human Medicines Highlights available
>> Find out more
No to abiraterone in England & Wales
>> Find out more
Vitamin E supplements linked to prostate cancer risk
>> Find out more
Aspirin: cancer prevention benefits outweigh risks for 55-75 age group
>> Find out more
How does prenatal chemotherapy exposure affect children?
>> Find out more
Colonoscopy with adenoma removal cut colorectal cancer deaths by 53%
>> Find out more
Warning about counterfeit Avastin
>> Find out more